July 28, 2011 — The latest update of long-term data on tamoxifen in early-stage breast cancer confirm and further define the benefit of the drug. In women with estrogen-receptor (ER)-positive disease, ...

In this segment, Dr. Gregory Vidal explains how biomarker test results directly influence treatment decisions in ER-positive, HER2-negative metastatic breast cancer. In this segment, Dr. Gregory Vidal ...

Giredestrant significantly improved progression-free survival in ER-positive advanced breast cancer, marking a milestone in SERD regimen trials. The trial met co-primary endpoints, benefiting patients ...

SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Genentech, a member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY), announced today positive results from the Phase III evERA study evaluating ...

Imlunestrant is approved for ER-positive, HER2-negative, ESR1-mutated advanced or metastatic breast cancer, showing improved progression-free survival with abemaciclib. The oral administration of ...

Patients with estrogen-receptor-positive HER-2-negative advanced breast cancer showed significantly improved progression-free survival when treated with an oral combination regimen that includes ...

Patients with estrogen-receptor-positive HER-2-negative advanced breast cancer showed significantly improved progression-free survival when treated with an oral combination regimen that includes ...

Sacituzumab govitecan combined with pembrolizumab improved progression-free survival in PD-L1–positive metastatic triple-negative breast cancer compared with chemotherapy. Vepdegestrant, a PROTAC ...

In preclinical studies, researchers at Sylvester Comprehensive Cancer Center, part of the University of Miami Miller School of Medicine, have tested a new combination therapy for hormone-resistant, ...

What The Latest NCCN and ASCO Guidelines Mean for HR-Positive Breast Cancer Treatment Optimizing Metastatic HR-Positive Breast Cancer Treatment: The Role of Molecular Testing William J. Gradishar, MD, ...

Breast cancer is one of the most common types of cancer in women in the United States. Each year, approximately 30% of newly diagnosed cancers in women are breast cancer. There are many treatments ...

Your breast cancer pathology report is one of the most important documents you’ll get during the diagnostic process. It can be packed with information and may include many strange-sounding terms. If ...